triterpene immunosuppressants (Novartis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametriterpene immunosuppressants (Novartis)
Drug Alias Namedammarols (Novartis)triterpenes anti-inflammatories (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsInflammationImmune System DiseasesAlopecia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsInflammationImmune System DiseasesAlopecia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A